Advertisement
Retraction
Open Access |
10.1172/JCI211875
Find articles by Ming, S. in: PubMed | Google Scholar
Find articles by Li, X. in: PubMed | Google Scholar
Find articles by Xiao, Q. in: PubMed | Google Scholar
Find articles by Qu, S. in: PubMed | Google Scholar
Find articles by Wang, Q. in: PubMed | Google Scholar
Find articles by Fang, Q. in: PubMed | Google Scholar
Find articles by Liang, P. in: PubMed | Google Scholar
Find articles by Xu, Y. in: PubMed | Google Scholar
Find articles by Yang, J. in: PubMed | Google Scholar
Find articles by Yang, Y. in: PubMed | Google Scholar
Find articles by Huang, X. in: PubMed | Google Scholar
Find articles by
Wu, Y.
in:
PubMed
|
Google Scholar
|
Published September 1, 2026 - More info
Impaired fatty acid oxidation (FAO) and the therapeutic benefits of FAO restoration have been revealed in sepsis. However, the regulatory factors contributing to FAO dysfunction during sepsis remain inadequately clarified. In this study, we identified a subset of lipid-associated macrophages characterized by high expression of trigger receptor expressed on myeloid cells 2 (TREM2) and demonstrated that TREM2 acted as a suppressor of FAO to increase the susceptibility to sepsis. TREM2 expression was markedly upregulated in sepsis patients and correlated with the severity of sepsis. Knockout of TREM2 in macrophages improved the survival rate and reduced inflammation and organ injuries of sepsis mice. Notably, TREM2-deficient mice exhibited decreased triglyceride accumulation and an enhanced FAO rate. Further observations showed that the blockade of FAO substantially abolished the alleviated symptoms observed in TREM2-knockout mice. Mechanically, we demonstrated that TREM2 interacted with the phosphatase SHP1 to inhibit bruton tyrosine kinase–mediated (BTK-mediated) FAO in sepsis. Our findings expand the understanding of FAO dysfunction in sepsis and reveal TREM2 as a critical regulator of FAO that may provide a promising target for the clinical treatment of sepsis.
Siqi Ming, Xingyu Li, Qiang Xiao, Siying Qu, Qiaohua Wang, Qiongyan Fang, Pingping Liang, Yating Xu, Jingwen Yang, Yongqiang Yang, Xi Huang, Yongjian Wu
Original citation: J Clin Invest. 2025;135(1):e159400. https://doi.org/10.1172/JCI159400
Citation for this retraction: J Clin Invest. 2026;136(17):e211875. https://doi.org/10.1172/JCI211875
At the request of the corresponding author, the JCI is retracting this article. The authors recently became aware that in Figure 5F and 5G, the fatty acid oxidation (FAO) rates reported were incorrect due to a failure to normalize the data to the protein concentration in the lysates. After properly normalizing the FAO data, the authors found that treatment with ibrutinib or LFM-A13 did not rescue the FAO rate in TREM2-deficient macrophages. Given the importance of these figures in supporting the key findings of the paper, the authors felt that retraction was the most responsible course of action.
The authors apologize for the errors.
See the related article at TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis.